Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.3926
-0.0074 (-1.85%)
Aug 7, 2025, 3:58 PM EDT
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$451,381
Profits / Employee
-$553,543
Market Cap
89.13M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 105 | -4 | -3.67% |
Dec 31, 2023 | 109 | -55 | -33.54% |
Dec 31, 2022 | 164 | 54 | 49.09% |
Dec 31, 2021 | 110 | 82 | 292.86% |
Dec 31, 2020 | 28 | 14 | 100.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Vaxart News
- 14 days ago - Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq - GlobeNewsWire
- 7 weeks ago - Vaxart Announces Preliminary Results of Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - GlobeNewsWire
- 2 months ago - Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial - GlobeNewsWire
- 2 months ago - Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart - Business Wire
- 2 months ago - Vaxart Announces Adjournment of Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 - GlobeNewsWire
- 2 months ago - Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders - GlobeNewsWire